Chronic effects of selective endothelin ETA or ETB receptor antagonist on cardiac dysfunction in the J-2-N cardiomyopathic hamsters

被引：0
|
作者：
Nishida, M
Hayashi, T
Ieshima, M
Eshiro, K
Akiyoshi, K
Takaoka, M
Matsumura, Y
机构：
[1] Osaka Univ Pharmaceut Sci, Dept Pharmacol, Osaka 5691094, Japan
[2] Osaka Med Coll, Dept Med 3, Takatsuki, Osaka 5691094, Japan
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 2002年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P795
引用
收藏
页码：260P / 260P
页数：1
相关论文
共 50 条
  • [1] Adverse hemodynamic effects of a selective endothelin ETB receptor antagonist in patients with chronic heart failure:: reversal with a selective endothelin ETA receptor antagonist
    Cowburn, PJ
    Cleland, JGF
    McDonagh, TA
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    CIRCULATION, 1998, 98 (17) : 718 - 718
  • [2] Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure
    Ohnishi, M
    Wada, A
    Tsutamoto, T
    Fukai, D
    Kinoshita, M
    CARDIOVASCULAR RESEARCH, 1998, 39 (03) : 617 - 624
  • [3] ABNORMALITIES OF ADP/ATP CARRIER PROTEIN IN J-2-N CARDIOMYOPATHIC HAMSTERS
    KATO, M
    JIE, Y
    IWAI, T
    TANAMURA, A
    ARINO, T
    KAWASHIMA, O
    TAKEDA, N
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 119 (1-2) : 89 - 94
  • [4] Selective endothelin ETB receptor antagonist improves left ventricular function but exaggerates degeneration of cardiomyocytes in J2N-k hamsters
    Nishida, M
    Hayashi, T
    Ieshima, M
    Eshiro, K
    Akiyoshi, K
    Takaoka, M
    Yoshiyama, M
    Yoshikawa, J
    Mori, T
    Okada, Y
    Kitaura, Y
    Matsumura, Y
    CIRCULATION JOURNAL, 2005, 69 (01) : 107 - 113
  • [5] Effects on haemodynamics by selective endothelin ETB receptor and combined endothelin ETA/ETB receptor antagonism during endotoxin shock
    Wanecek, M
    Oldner, A
    Sundin, P
    Alving, K
    Weitzberg, E
    Rudehill, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 386 (2-3) : 235 - 245
  • [6] Effect of chronic treatment with a selective endothelin ETA antagonist, a selective ETB antagonist or their combination in a rat model of chronic heart failure
    Mulder, P
    Boujedaini, H
    Derumeaux, G
    Richard, V
    Henry, JP
    Wessale, J
    Opgenorth, T
    Thuillez, C
    EUROPEAN HEART JOURNAL, 2000, 21 : 115 - 115
  • [7] BENEFICIAL-EFFECTS OF NIFEDIPINE ON CARDIOMYOPATHIC HAMSTER J-2-N
    KATO, M
    YANG, J
    ARINO, T
    TSUCHIYA, M
    TAKEDA, N
    NAGANO, M
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 : S91 - S91
  • [8] Beneficial effect of a new endothelin antagonist, TA-0201, on survival and cardiac dysfunction in cardiomyopathic hamsters
    Yamauti-Kohno, R
    Miyauchi, T
    Hoshino, T
    Kobayashi, T
    Aihara, H
    Sakai, S
    Yabana, H
    Goto, K
    Murata, S
    Sugishita, Y
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R639 - R639
  • [9] Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure
    Wada, A
    Tsutamoto, T
    Fukai, D
    Ohnishi, M
    Maeda, K
    Hisanaga, T
    Maeda, Y
    Matsuda, Y
    Kinoshita, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (05) : 1385 - 1392
  • [10] CARDIAC ENZYMATIC ALTERATIONS IN KESHAN DISEASE-MODEL AND CARDIOMYOPATHIC HAMSTER J-2-N
    YANG, J
    KATO, M
    TAKEDA, N
    NAGANO, M
    YANG, TS
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 : S57 - S57
12345